Stay updated on NT-814 Efficacy in Menopausal Symptoms Clinical Trial
Sign up to get notified when there's something new on the NT-814 Efficacy in Menopausal Symptoms Clinical Trial page.

Latest updates to the NT-814 Efficacy in Menopausal Symptoms Clinical Trial page
- Check4 days agoChange DetectedNew Revision: v3.3.4 appears on the page, while the prior Revision: v3.3.3 entry is removed. This represents a minor backend/version update with no impact on the study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe locations are now listed under a new top-level 'Locations' section with consolidated country/region entries, replacing the previous separate state-specific headings; the HHS Vulnerability Disclosure link is removed and the page revision is updated to v3.3.3.SummaryDifference0.9%

- Check55 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedThe government funding lapse notice was removed from the page. All other study details, locations, and planned outcomes remain the same.SummaryDifference0.3%

- Check76 days agoChange DetectedLayout and navigation of the study details page were updated. Core elements such as study design, interventions, outcomes, and eligibility criteria appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check105 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0; this changes how users view current operations and the release version.SummaryDifference1%

Stay in the know with updates to NT-814 Efficacy in Menopausal Symptoms Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NT-814 Efficacy in Menopausal Symptoms Clinical Trial page.